These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prazosin treatment of Raynaud's phenomenon: a double blind single crossover study. Russell IJ; Lessard JA J Rheumatol; 1985 Feb; 12(1):94-8. PubMed ID: 3884807 [TBL] [Abstract][Full Text] [Related]
8. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension. Frishman WH; Eisen G; Lapsker J Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of Raynaud's phenomenon with alpha-lytic agents]. Clément DL Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369 [No Abstract] [Full Text] [Related]
10. Therapeutic efficacy of alpha-adrenoceptor blockade in primary and secondary Raynaud's syndrome. Cleophas TJ; van Lier HJ; Faaber P; Fennis JF; van't Laar A Angiology; 1984 Nov; 35(11):719-23. PubMed ID: 6149709 [TBL] [Abstract][Full Text] [Related]
11. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Surwit RS; Gilgor RS; Allen LM; Duvic M Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665 [TBL] [Abstract][Full Text] [Related]
13. The origin of Raynaud's phenomenon. Nielubowicz J; Zajaç S; Szamowska R; Adamski M J Cardiovasc Surg (Torino); 1978; 19(6):607-14. PubMed ID: 739033 [TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon? Tagliarino H; Purdon M; Jamieson B; Hoekzema G J Fam Pract; 2005 Jun; 54(6):553-5. PubMed ID: 15939010 [No Abstract] [Full Text] [Related]
15. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis]. Serri J; Legré R; Veit V; Guardia C; Gay AM Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894 [TBL] [Abstract][Full Text] [Related]
16. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease. Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066 [TBL] [Abstract][Full Text] [Related]